An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss

Medical Journal of Australia

Volumn 175, Issue 5, 2001, Pages 242-245

  Cleghorn, D B ^a   O'Loughlin, P D ^a   Schroeder, B J ^a   Nordin, B E C ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; DEOXYPYRIDINOLINE; HYDROXYPROLINE; MINERAL;

ADULT; ARTICLE; AUSTRALIA; BODY DENSITY; BONE ATROPHY; CALCIUM INTAKE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG EFFECT; EARLY MENOPAUSE; FEMALE; FOREARM; HUMAN; HYDROXYPROLINE URINE LEVEL; MILK; OSTEOLYSIS; POSTMENOPAUSE; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; SPINE; URINARY EXCRETION; URINE LEVEL;

EID: 0035801710     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2001.tb143554.x     Document Type: Article

References (23)

1. Osteomalacia, osteoporosis and calcium deficiency
2. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis
3. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
4. Bone remodeling: Relationship to the amount and structure of bone and the pathogenesis and prevention of fractures
5. Cancellous bone remodeling in Type I (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
6. Effect of perimenopause on calcium absorption: A longitudinal study
7. Evidence for a renal calcium leak in postmenopausal women
8. Biochemical variables in pre- and postmenopausal women: Reconciling the calcium and estrogen hypotheses
9. Calcium and osteoporosis
10. Calcium potentiates the effect of estrogen and calcitonin on bone mass: Review and analysis
11. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
12. The calcium controversy revisited: Implications of new data
13. Nutritional considerations
14. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links
15. The determination of hydroxyproline in urine hydrolysates
16. Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: Results of a prospective study
17. Metabolic consequences of the menopause. A cross-sectional, longitudinal, and intervention study on 557 normal postmenopausal women
18. Treatment of established postmenopausal osteoporosis with raloxifene: A randomized trial
19. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
20. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial
21. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: Results of a randomized controlled clinical trial
22. Calcium supplementation suppresses bone resorption in early postmenopausal women
23. Monitoring individual response to hormone replacement therapy with bone markers